The Valley Desk

NCT05155085 · Interventional trial

A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis

Overall registry status Terminated

Phase 2

Conditions Atopic Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov